A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382

α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

(1998) · Europe PMC (PubMed Central) · Cited by 1,594

Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,520

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J. D. M., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,469

The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316

Identification of two distinct synucleins from human brain

Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080

Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,052

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch

George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844

Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: Implications for the prevention and therapeutics of Lewy body diseases

Ono, K., Hirohata, M., & Yamada, M. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.002 · Cited by 51

α-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic Challenges

Arias-Carrión, Ó., Guerra‐Crespo, M., Padilla-Godínez, F. J., Soto-Rojas, L. O., & Manjarrez, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115405 · Cited by 51

Altered Conformation of α-Synuclein Drives Malfunction of Synaptic Vesicles in a Model of Parkinson's Disease

Fonseca‐Ornelas, L., Viennet, T., Rovere, M., Jiang, H., Liu, L., Nuber, S., Ericsson, M., Arthanari, H., & Selkoe, D. J. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.109333 · Cited by 52

- α-Synuclein and Parkinson’s Disease

Gasser, T. (2012) · CRC Press eBooks · doi:10.1201/b12948-15 · Cited by 50

Alternative Splicing of Alpha- and Beta-Synuclein Genes Plays Differential Roles in Synucleinopathies

Gámez‐Valero, A., & Beyer, K. (2018) · Genes · doi:10.3390/genes9020063 · Cited by 51

Minimalist Prion-Inspired Polar Self-Assembling Peptides

Díaz-Caballero, M., Navarro, S., Fuentes, I., Teixidor, F., & Ventura, S. (2018) · ACS Nano · doi:10.1021/acsnano.8b00417 · Cited by 49

Sequence and structure-based peptides as potent amyloid inhibitors: A review

Mitra, A., & Sarkar, N. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108614 · Cited by 50

Simulation Studies on the Stabilities of Aggregates Formed by Fibril-Forming Segments of α-Synuclein

Yoon, J., Jang, S., Lee, K., & Shin, S. (2009) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2009.10507314 · Cited by 49

Understanding amyloid fibril formation using protein fragments: structural investigations via vibrational spectroscopy and solid-state NMR

Martial, B., Lefèvre, T., & Auger, M. (2018) · Biophysical Reviews · doi:10.1007/s12551-018-0427-2 · Cited by 50

Proteinase K resistant cores of prions and amyloids

Kushnirov, V. V., Dergalev, A. A., & Alexandrov, A. I. (2019) · Prion · doi:10.1080/19336896.2019.1704612 · Cited by 48

Familial conformational diseases and dementias

Crowther, D. C. (2002) · Human Mutation · doi:10.1002/humu.10100 · Cited by 48

Functional ryanodine receptors are expressed by human microglia and THP‐1 cells: Their possible involvement in modulation of neurotoxicity

Klegeris, A., Choi, H. B., McLarnon, J. G., & McGeer, P. L. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21361 · Cited by 47

Lipid dysfunction and pathogenesis of multiple system atrophy

Bleasel, J. M., Wong, J. H., Halliday, G. M., & Kim, W. S. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-15 · Cited by 47

Computational insights into the role of α-strand/sheet in aggregation of α-synuclein

Balupuri, A., Choi, K.-E., & Kang, N. S. (2019) · Scientific Reports · doi:10.1038/s41598-018-37276-1 · Cited by 48

α-Synuclein and its neurotoxic fragment inhibit dopamine uptake into rat striatal synaptosomes

Adamczyk, A., Wilkaniec, A., & Strosznajder, J. B. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.01.025 · Cited by 47

α-Synuclein Aggregation: A Link Between Mitochondrial Defects and Parkinson's Disease?

Lee, S. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603322110904 · Cited by 48

A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversity

Kumar, S. T., Mahul‐Mellier, A., Hegde, R. N., Moons, R., Magalhães, P., de Opakua, A. I., Riviere, G., Rostami, I., Donzelli, S., Zweckstetter, M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn0044 · Cited by 48

Sensitive Fluorescence Polarization Technique for Rapid Screening of α-Synuclein Oligomerization/Fibrillization Inhibitors

Luk, K. C., Hyde, E. G., Trojanowski, J. Q., & Lee, V. M. ‐. (2007) · Biochemistry · doi:10.1021/bi701128c · Cited by 46

Protein Quality Control Pathways at the Crossroad of Synucleinopathies

de Mattos, E. P., Wentink, A. S., Nussbaum-Krammer, C. I., Hansen, C., Bergink, S., Melki, R., & Kampinga, H. H. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-191790 · Cited by 46

Assembly of Lysine 63-linked Ubiquitin Conjugates by Phosphorylated α-Synuclein Implies Lewy Body Biogenesis

Liu, C., Fei, E., Jia, N., Wang, H., Tao, R.-S., Iwata, A., Nukina, N., Zhou, J., & Wang, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700422200 · Cited by 45

Unsaturation in the Fatty Acids of Phospholipids Drastically Alters the Structure and Toxicity of Insulin Aggregates Grown in Their Presence

Matveyenka, M., Rizevsky, S., & Kurouski, D. (2022) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.2c00559 · Cited by 44

α-Synuclein Conformational Strains as Drivers of Phenotypic Heterogeneity in Neurodegenerative Diseases

So, R. W. L., & Watts, J. C. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168011 · Cited by 46

Parkinsons Disease: Genetics and Beyond

Inamdar, N., Arulmozhi, D. K., Tandon, A., & Bodhankar, S. L. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866893 · Cited by 46

α-Synuclein in Parkinson's Disease: Pathogenic Function and Translation into Animal Models

Eschbach, J., & Danzer, K. M. (2013) · Neurodegenerative Diseases · doi:10.1159/000354615 · Cited by 45

Vibrational Circular Dichroism Reveals Supramolecular Chirality Inversion of α-Synuclein Peptide Assemblies upon Interactions with Anionic Membranes

Martial, B., Lefèvre, T., Buffeteau, T., & Auger, M. (2019) · ACS Nano · doi:10.1021/acsnano.8b08932 · Cited by 44

Using protein engineering to understand and modulate aggregation

Ebo, J. S., Guthertz, N., Radford, S. E., & Brockwell, D. J. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.01.005 · Cited by 44

α‐Synuclein phase separation and amyloid aggregation are modulated by C‐terminal truncations

Huang, S., Mo, X., Wang, J., Ye, X., Yu, H., & Liu, Y. (2022) · FEBS Letters · doi:10.1002/1873-3468.14361 · Cited by 44

Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective

Knecht, L. H., Folke, J., Dodel, R. C., Ross, J. A., & Albus, A. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01288-7 · Cited by 44

α-Synuclein TransgenicDrosophilaAs a Model of Parkinson's Disease and Related Synucleinopathies

Mizuno, H., Fujikake, N., Wada, K., & Nagai, Y. (2010) · Parkinson s Disease · doi:10.4061/2011/212706 · Cited by 47

α-Synuclein: A therapeutic target for Parkinson’s disease?

Maguire‐Zeiss, K. A. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.09.006 · Cited by 44

Toward the Discovery of Effective Polycyclic Inhibitors of α-Synuclein Amyloid Assembly

Lamberto, G. R., Monserrat, V. T., Bertoncini, C. W., Salvatella, X., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.242958 · Cited by 44

Dysfunction of Synaptic Vesicle Endocytosis in Parkinson’s Disease

Zou, L., Tian, Y., & Zhang, Z. (2021) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2021.619160 · Cited by 44

The role of His-50 of α-synuclein in binding Cu(ii): pH dependence, speciation, thermodynamics and structure

Valensin, D., Camponeschi, F., Łuczkowski, M., Baratto, M. C., Remelli, M., Valensin, G., & Kozłowski, H. (2011) · Metallomics · doi:10.1039/c0mt00068j · Cited by 43

Nanoimaging for protein misfolding diseases

Lyubchenko, Y. L., Kim, B., Krasnoslobodtsev, A. V., & Yu, J. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.102 · Cited by 44

A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues

Moriarty, G. M., Olson, M. P., Atieh, T. B., Janowska, M. K., Khare, S. D., & Baum, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.780528 · Cited by 43

Vaccination strategies in tauopathies and synucleinopathies

Braczynski, A. K., Schulz, J. B., & Bach, J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14207 · Cited by 44

Comparative analyses of the in vivo induction and transmission of α-synuclein pathology in transgenic mice by MSA brain lysate and recombinant α-synuclein fibrils

Dhillon, J.-K. S., Trejo‐Lopez, J. A., Riffe, C. J., Levites, Y., Sacino, A. N., Borchelt, D., Yachnis, A. T., & Giasson, B. I. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0733-3 · Cited by 47

Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson’s Disease

Hernandez, S. M., Tikhonova, E. B., & Karamyshev, A. L. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00072 · Cited by 45

Living with the enemy: from protein-misfolding pathologies we know, to those we want to know

Emwas, A.-H. M., Alghrably, M., Dhahri, M., Sharfalddin, A. A., Alsiary, R., Jaremko, M., Faa, G., Campagna, M., Congiu, T., Piras, M., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101391 · Cited by 43

Understanding Caffeine’s Role in Attenuating the Toxicity of α-Synuclein Aggregates: Implications for Risk of Parkinson’s Disease

Kardani, J., & Roy, I. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00158 · Cited by 43

α-Synuclein: A potent inducer of tau pathology

Geddes, J. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.002 · Cited by 45

Genetic factors involved in the pathogenesis of Parkinson's disease

Lee, F. J. S., & Liu, F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.02.001 · Cited by 43

Neuroimaging for Lewy body disease: Is the in vivo molecular imaging of α-synuclein neuropathology required and feasible?

Vernon, A. C., Ballard, C. G., & Modo, M. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.05.006 · Cited by 44

Alpha‐synuclein and its role in metal binding: Relevance to Parkinson's disease

Wright, J. A., & Brown, D. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21461 · Cited by 44

Structures and Free Energy Landscapes of the Wild-Type and A30P Mutant-Type α-Synuclein Proteins with Dynamics

Wise-Scira, O., Aloglu, A. K., Dunn, A., Sakallioglu, I. T., & Coskuner‐Weber, O. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn300198q · Cited by 43

A light-inducible protein clustering system for in vivo analysis of α-synuclein aggregation in Parkinson disease

Bérard, M., Sheta, R., Malvaut, S., Rodríguez-Aller, R., Teixeira, M., Idi, W., Turmel, R., Alpaugh, M., Dubois, M., Dahmene, M., et al. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001578 · Cited by 42

Membrane‐bound structure and energetics of α‐synuclein

Mihajlovic, M., & Lazaridis, T. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21558 · Cited by 42

Amyloids of Alpha-Synuclein Affect the Structure and Dynamics of Supported Lipid Bilayers

Iyer, A., Petersen, N. O., Claessens, M. M. A. E., & Subramaniam, V. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.05.001 · Cited by 42

α-Synuclein nonhuman primate models of Parkinson’s disease

Marmion, D. J., & Kordower, J. H. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1720-0 · Cited by 44

Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson’s Disease

Yaribash, S., Mohammadi, K., & Sani, M. A. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01544-2 · Cited by 44

Understanding co-polymerization in amyloid formation by direct observation of mixed oligomers

Young, L. M., Tu, L., Raleigh, D. P., Ashcroft, A. E., & Radford, S. E. (2017) · Chemical Science · doi:10.1039/c7sc00620a · Cited by 41

Femtosecond Hydration Map of Intrinsically Disordered α-Synuclein

Arya, S., Singh, A. K., Bhasne, K., Dogra, P., Datta, A., Das, P., & Mukhopadhyay, S. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.04.028 · Cited by 41

Characterization of fibrillation process of α-synuclein at the initial stage

Tashiro, M., Kojima, M., Kihara, H., Kasai, K., Kamiyoshihara, T., Uéda, K., & Shimotakahara, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.127 · Cited by 41

Tau- and α-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases

Tapia-Arellano, A., Cabrera, P., Cortés-Adasme, E., Riveros, A. L., Hassan, N., & Kogan, M. J. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02526-0 · Cited by 40

Nucleic acid-mediated protein aggregation and assembly

Liu, C., & Zhang, Y. (2011) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-386483-3.00005-7 · Cited by 42

Localized Induction of Wild-Type and Mutant Alpha-Synuclein Aggregation Reveals Propagation along Neuroanatomical Tracts

Ayers, J. I., Riffe, C. J., Sorrentino, Z. A., Diamond, J., Fagerli, E., Brooks, M., Galaleldeen, A., Hart, P. J., & Giasson, B. I. (2018) · Journal of Virology · doi:10.1128/jvi.00586-18 · Cited by 40

Reverse engineering synthetic antiviral amyloids

Michiels, E., Roose, K., Gallardo, R. U., Khodaparast, L., Khodaparast, L., van der Kant, R., Siemons, M., Houben, B., Ramakers, M., Wilkinson, H. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16721-8 · Cited by 40

A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease

Fevga, C., Park, Y., Lohmann, E., Kievit, A. J. A., Breedveld, G. J., Ferraro, F., de Boer, L., van Minkelen, R., Hanagasi, H. A., Boon, A. J. W., et al. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.06.023 · Cited by 39

T cells, α-synuclein and Parkinson disease

Garretti, F., Monahan, C., Sette, A., Agalliu, D., & Sulzer, D. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00023-0 · Cited by 39

Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease

Allen, S. G., Meade, R. M., Stenner, L. L. W., & Mason, J. M. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00675-8 · Cited by 39

Biophysical groundwork as a hinge to unravel the biology of α-synuclein aggregation and toxicity

Plotegher, N., Greggio, E., Bisaglia, M., & Bubacco, L. (2014) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583513000097 · Cited by 40

β-Sheet-breaking peptides inhibit the fibrillation of human α-synuclein

Kim, Y. S., Lim, D., Kim, J. Y., Kang, S. J., Kim, Y. H., & Im, H. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.083 · Cited by 39

Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?

Greggio, E., Bisaglia, M., Civiero, L., & Bubacco, L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-6 · Cited by 43

Structural and Sequence Analysis of the Human γD-Crystallin Amyloid Fibril Core Using 2D IR Spectroscopy, Segmental 13C Labeling, and Mass Spectrometry

Moran, S. D., Decatur, S. M., & Zanni, M. T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307898g · Cited by 39

Raman optical activity of human α‐synuclein in intrinsically disordered, micelle‐bound α‐helical, molten globule and oligomeric β‐sheet state

Mensch, C., Konijnenberg, A., Elzen, R. V., Lambeir, A., Sobott, F., & Johannessen, C. (2017) · Journal of Raman Spectroscopy · doi:10.1002/jrs.5149 · Cited by 39

Computational affinity maturation of camelid single-domain intrabodies against the nonamyloid component of alpha-synuclein

Mahajan, S. P., Meksiriporn, B., Waraho‐Zhmayev, D., Weyant, K. B., Koçer, İ., Butler, D. C., Messer, A. C., Escobedo, F. A., & DeLisa, M. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-35464-7 · Cited by 41

Nanoscale Structural Analysis of a Lipid-Driven Aggregation of Insulin

Rizevsky, S., Matveyenka, M., & Kurouski, D. (2022) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c04012 · Cited by 38

Lipids uniquely alter rates of insulin aggregation and lower toxicity of amyloid aggregates

Matveyenka, M., Rizevsky, S., Pellois, J., & Kurouski, D. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159247 · Cited by 38

Cellular Uptake of α-Synuclein Oligomer-Selective Antibodies is Enhanced by the Extracellular Presence of α-Synuclein and Mediated via Fcγ Receptors

Gustafsson, G., Eriksson, F., Möller, C., da Fonseca, T. L., Outeiro, T. F., Lannfelt, L., Bergström, J. J. E., & Ingelsson, M. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0352-5 · Cited by 38

Critical nucleus of Greek-key-like core of α-synuclein protofibril and its disruption by dopamine and norepinephrine

Zou, Y. F., Qian, Z., Gong, Y., Tang, Y., Wei, G., & Zhang, Q. (2019) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp04610k · Cited by 38

The A53E α-synuclein pathological mutation demonstrates reduced aggregation propensity in vitro and in cell culture

Rutherford, N. J., & Giasson, B. I. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.04.022 · Cited by 38

Neuritic Alterations and Neural System Dysfunction in Alzheimer's Disease and Dementia with Lewy Bodies

Klucken, J., McLean, P. J., Gómez‐Tortosa, E., Ingelsson, M., & Hyman, B. T. (2003) · Neurochemical Research · doi:10.1023/a:1026061021946 · Cited by 38

The Transcellular Propagation and Intracellular Trafficking of α-SynucleinPreprint

Tofaris, G. K., Goedert, M., & Spillantini, M. G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024380 · Cited by 39

A Proposed Atomic Structure of the Self-Assembly of the Non-Amyloid-β Component of Human α-Synuclein As Derived by Computational Tools

Atsmon‐Raz, Y., & Miller, Y. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b03760 · Cited by 37

14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model

Underwood, R., Gannon, M. A., Pathak, A., Kapa, N., Chandra, S., Klop, A., & Yacoubian, T. A. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01110-5 · Cited by 37

Transglutaminase-mediated Intramolecular Cross-linking of Membrane-bound α-Synuclein Promotes Amyloid Formation in Lewy Bodies

Nemes, Z., Petrovski, G., Aerts, M., Sergeant, K., Devreese, B. V., & Fésüs, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033969 · Cited by 37

Adsorption of α-Synuclein on Lipid Bilayers: Modulating the Structure and Stability of Protein Assemblies

Haque, F., Pandey, A. P., Cambrea, L. R., Rochet, J., & Hovis, J. S. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp1006704 · Cited by 37

Rupture Force Analysis and the Associated Systematic Errors in Force Spectroscopy by AFM

Ray, C., Brown, J. R., & Akhremitchev, B. B. (2007) · Langmuir · doi:10.1021/la070131e · Cited by 37

Conserved core of amyloid fibrils of wild type and A30P mutant α‐synuclein

Cho, M., Kim, H., Fernández, C. O., Becker, S., & Zweckstetter, M. (2010) · Protein Science · doi:10.1002/pro.570 · Cited by 37

α-Synuclein Misfolding Assessed with Single Molecule AFM Force Spectroscopy: Effect of Pathogenic Mutations

Krasnoslobodtsev, A. V., Volkov, I. L., Asiago, J. M., Hindupur, J., Rochet, J., & Lyubchenko, Y. L. (2013) · Biochemistry · doi:10.1021/bi401037z · Cited by 38

α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies

Bigi, A., Cascella, R., & Cecchi, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371345 · Cited by 38

The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson’s Disease

Battis, K., Xiang, W., & Winkler, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713270 · Cited by 38

The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson’s disease

Miao, Y., & Meng, H. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01402-y · Cited by 40

α‐Synuclein in Parkinson's Disease: From Bench to Bedside

Bellini, G., D’Antongiovanni, V., Palermo, G., Antonioli, L., Fornai, M., Ceravolo, R., Bernardini, N., Derkinderen, P., & Pellegrini, C. (2024) · Medicinal Research Reviews · doi:10.1002/med.22091 · Cited by 42

Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity

Čarija, A., Pinheiro, F., Pujols, J., Brás, I. C., Lázaro, D. F., Santambrogio, C., Grandori, R., Outeiro, T. F., Navarro, S., & Ventura, S. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101135 · Cited by 39

Synphilin in normal human brains and in synucleinopathies: studies with new antibodies

Murray, I. V. J., Medford, M. A., Guan, H.-P., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M. ‐. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0629-2 · Cited by 36

The impact of hUC MSC–derived exosome-nanoliposome hybrids on α-synuclein fibrillation and neurotoxicity

Aliakbari, F., Marzookian, K., Parsafar, S., Hourfar, H., Nayeri, Z., Fattahi, A., Raeiji, M., Boroujeni, N. N., Otzen, D. E., & Morshedi, D. (2024) · Science Advances · doi:10.1126/sciadv.adl3406 · Cited by 37

Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions

Lam, I., Ndayisaba, A., Lewis, A. J., Fu, Y., Sagredo, G. T., Kuzkina, A., Zaccagnini, L., Celikag, M., Sandoe, J., Sanz, R. L., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.06.002 · Cited by 37

Synthesis of d-amino acid peptides and their effect on beta-amyloid aggregation and toxicity in transgenic Caenorhabditis elegans

Jagota, S., & Rajadas, J. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0386-2 · Cited by 35

Mechanisms and therapeutic potential of interactions between human amyloids and viruses

Michiels, E., Rousseau, F., & Schymkowitz, J. W. H. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03711-8 · Cited by 37

Consequences of variability in α-synuclein fibril structure on strain biology

Holec, S. A. M., Liu, S. L., & Woerman, A. L. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02403-w · Cited by 35

The Cell Biology of α Synuclein

Cole, N. B., & Murphy, D. D. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:1:2:95 · Cited by 35

Adeno-Associated Virus Expression of α-Synuclein as a Tool to Model Parkinson’s Disease: Current Understanding and Knowledge Gaps

Huntington, T. E., & Srinivasan, R. (2021) · Aging and disease · doi:10.14336/ad.2021.0517 · Cited by 34

Lipids uniquely alter secondary structure and toxicity of lysozyme aggregates

Matveyenka, M., Zhaliazka, K., Rizevsky, S., & Kurouski, D. (2022) · The FASEB Journal · doi:10.1096/fj.202200841r · Cited by 35

Taking Charge: Metal Ions Accelerate Amyloid Aggregation in Sequence Variants of α-Synuclein

Byrd, E. J., Wilkinson, M., Radford, S. E., & Sobott, F. (2023) · Journal of the American Society for Mass Spectrometry · doi:10.1021/jasms.2c00379 · Cited by 34

Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice

Rutherford, N. J., Sacino, A. N., Brooks, M., Ceballos‐Diaz, C., Ladd, T. B., Howard, J. K., Golde, T. E., & Giasson, B. I. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0029-4 · Cited by 34

Intrabodies as Neuroprotective Therapeutics

Messer, A. C., & Joshi, S. N. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0193-6 · Cited by 35

Coupling of the non-amyloid-component (NAC) domain and the KTK(E/Q)GV repeats stabilize the α-synuclein fibrils

Xu, L., Nussinov, R., & Ma, B. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.01.044 · Cited by 34

Probing Conformational Change of Intrinsically Disordered α-Synuclein to Helical Structures by Distinctive Regional Interactions with Lipid Membranes

Lee, S. J. C., Lee, J. W., Choi, T. S., Jin, K. S., Lee, S., Ban, C., & Kim, H. I. (2014) · Analytical Chemistry · doi:10.1021/ac404132g · Cited by 34

Amyloid self‐assembling peptides: Potential applications in nanovaccine engineering and biosensing

Soultan, A. H., Babych, M., Zottig, X., Archambault, D., & Bourgault, S. (2018) · Peptide Science · doi:10.1002/pep2.24095 · Cited by 34

Characterization of Hydrophobic Residue Requirements for α-Synuclein Fibrillization

Waxman, E. A., Mazzulli, J. R., & Giasson, B. I. (2009) · Biochemistry · doi:10.1021/bi900539p · Cited by 110

A Peptide Motif Consisting of Glycine, Alanine, and Valine Is Required for the Fibrillization and Cytotoxicity of Human α-Synuclein

Du, H., Tang, L., Luo, X., Li, H., Hu, J., Zhou, J., & Hu, H. (2003) · Biochemistry · doi:10.1021/bi034028+ · Cited by 155

Sequence determinants regulating fibrillation of human α-synuclein

Koo, H.-J., Lee, H.-J., & Im, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.140 · Cited by 55

Sequence Determinants for Amyloid Fibrillogenesis of Human α-Synuclein

Zibaee, S., Jakes, R., Fraser, G. M., Serpell, L. C., Crowther, R. A., & Goedert, M. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.09.039 · Cited by 67

A de novo designed α-helical peptide forms amyloid fibrils which are not neurotoxic

Fezoui, Y., Hartley, D. M., Walsh, D. M., Selkoe, D. J., Osterhut, J. J., & Teplow, D. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)82568-3